AUDEX

Xfer Records Serum 2 v2.1.2 [Windows]

Join our membership to be able to download premium files
Audex Team
Apr 26, 2026
Xfer Records Serum 2 v2.1.2 [Windows]
Xfer Records Serum 2 v2.1.2 [Windows]
Preview

Serum 2
Advanced Hybrid Synthesizer

Why Serum?

The original motivation for creating Serum was to have a dream synthesizer that did not exist: a wavetable synthesizer with a truly high-quality sound, a visual and creative workflow-oriented interface to make creating and altering sounds fun instead of tedious, and the ability to go deep when desired — to create, import, edit, and morph wavetables, and manipulate them on playback in real time.

Serum version 2 blasts the sonic palette wide open, offering the user incredible power, control, and expression over their sonic output. With many oscillator types, flexible effect routing, an arpeggiator, and a clip sequencer, the goal with Serum 2 was to empower Serum users to fully realize their sound and music ideas into form.

Did we mention that Serum 2 is a free upgrade for Serum 1 owners? Lifetime free updates actually means lifetime free updates.

Specs

Serum comes with over 626 presets and 288 wavetables.
Available as VST3, AU, and AAX 64-bit.

System Requirements

Windows: Windows 10+
Macintosh: High Sierra or later for Intel, or Big Sur or later for Apple Silicon.
64-bit VST3, AU, or AAX compatible host software.

Changelog [2.1.2] — 2026-03-31

Fixed crash when entering empty text into PZ SVF filter editor
Fixed crash when loading presets that use Slicing with Granular or Spectral
Fixed notes getting silenced if falling on the same timestamp as a preceding CC123 all-notes-off message
Fixed piano note roll preview triggering multiple of the same note
Fixed potential crash on undo after host setting state
Fixed sample edit window not resizable on Windows
Fixed selected skin not remembered when closing and reopening GUI
Improved GUI performance

Download

Download this premium file

Your membership is active. You can download this file instantly.
Community

Comments

Share your thoughts about this article. Please sign in before posting a comment.

No comments yet. Be the first to comment.